Greenland Mines Ltd. Company Profile
NASDAQ: GRMLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Greenland Mines at a glance
Greenland Mines Ltd. (NASDAQ: GRML) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Charlotte, NC. Greenland Mines is led by Dr. Joseph A. Sinkule Pharm.D. and employs about 5 people. The company's shares have traded publicly since 2022.
At a market capitalization of $44.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001907223, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Greenland Mines do?
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Business description based on the company's public filings.
Company information
- Legal name
- Greenland Mines Ltd.
- Ticker
- NASDAQ: GRML
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Dr. Joseph A. Sinkule Pharm.D.
- Employees
- 5
- Headquarters
- 1300 South Boulevard, Charlotte, NC, United States
- Phone
- 833 931 6330
- Website
- greenlandmines.com
- IPO year
- 2022
- Market cap
- $44.31M
- SEC CIK
- 0001907223
- Latest annual report
- 10-K/A · Aug 14, 2026
Companies similar to Greenland Mines
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELOXEloxx Pharmaceuticals Inc. | 10.69 | -1.75% | $43.69M | vs GRML |
| INKTMiNK Therapeutics Inc. | 8.02 | -6.85% | $41.17M | vs GRML |
| ELUTElutia Inc. Class A | 0.9001 | +11.12% | $39.96M | vs GRML |
| IMAImageneBio Inc. | 3.92 | 0.00% | $48.83M | vs GRML |
| TILInstil Bio Inc. | 5.23 | -5.77% | $35.47M | vs GRML |
| AVXLAnavex Life Sciences Corp. | 0.5915 | -11.39% | $54.83M | vs GRML |
| CGTXCognition Therapeutics Inc. | 0.5822 | -3.06% | $55.37M | vs GRML |
| OKYOOKYO Pharma Limited | 1.07 | -7.76% | $56.15M | vs GRML |